Amesite Stock Soars 190% on Major Enterprise Customer Win

Amesite Inc. (NASDAQ:AMST) shares rocketed 190% in premarket trading Tuesday after the company landed its largest enterprise customer to date, a deal that covers approximately 2,700 patients.

Under the agreement, the new customer will deploy NurseMagic AI documentation across its workforce, streamlining workflows while integrating the platform with its electronic medical record and electronic visit verification systems. Notably, the deployment aims to slash the administrative burden that currently eats up as much as 16 hours per caregiver each week.

Moreover, this win marks a substantial leap in scale for NurseMagic’s enterprise census footprint. According to the company, the platform will handle multiple roles, layered permissions, EMR and EVV integration, and custom documentation spanning thousands of patients.

Dr. Ann Marie Sastry, Founder and CEO of Amesite, emphasized the milestone’s significance: “This 2,700-census deployment validates the strength of our architecture. We are supporting multiple roles, layered permissions, EMR and EVV integration, and custom documentation across thousands of patients — without the heavy consulting, technology fees, and custom development that typically drive up pricing from legacy providers. Because NurseMagic™ is AI-first, automated, and configurable, we launch new customers quickly, without weeks or months of onboarding.”

In addition, Sarah Berman, Principal Finance and Accounting Officer, highlighted that the company executed the deployment while keeping a tight grip on costs. Specifically, Amesite trimmed operating spend by roughly 18% over the past six quarters even as its paying customer base expanded.

Meanwhile, Madison Bush, Director of Corporate Operations, pointed to strong top-of-funnel momentum, with sales and marketing efforts now driving approximately 4,200 web visits per day. Furthermore, the company is currently in discussions with additional organizations representing several thousand more patients in aggregate census — and impressively, over 70% of those prospects have self-scheduled demos directly on the website.